Astria Therapeutics, Inc.

NasdaqGM:ATXS Stock Report

Market Cap: US$471.2m

Astria Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:ATXS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Feb 24BuyUS$29,999,522Perceptive Advisors LLCCompany2,481,350US$12.09

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ATXS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders267,6980.444%
Private Companies2,872,5374.77%
Hedge Funds10,503,00517.4%
VC/PE Firms15,049,27825%
Institutions31,578,48652.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 55.5%.


Top Shareholders

Top 25 shareholders own 99.5% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.9%
FMR LLC
7,822,275US$65.3m29.2%no data
11.5%
Perceptive Advisors LLC
6,485,420US$54.2m0%1.28%
9.05%
RA Capital Management, L.P.
5,105,213US$42.6m1.22%0.54%
7.09%
Vestal Point Capital, LP
4,000,000US$33.4m23.1%2.66%
6.3%
Fairmount Funds Management LLC
3,554,129US$29.7m0%2.47%
6.2%
BlackRock, Inc.
3,499,478US$29.2m-0.51%no data
6.13%
VR Adviser, LLC
3,458,645US$28.9m-4.16%1.47%
5.23%
Millennium Management LLC
2,948,876US$24.6m18.6%0.02%
5.09%
Forgrowth Iii Pa Bv
2,872,537US$24.0m0%no data
4.89%
TCG Crossover Management, LLC
2,761,861US$23.1m0%2.09%
4.67%
The Vanguard Group, Inc.
2,635,520US$22.0m1.75%no data
2.87%
Driehaus Capital Management LLC
1,617,628US$13.5m-7.56%0.09%
2.76%
State Street Global Advisors, Inc.
1,556,283US$13.0m-24.2%no data
2.75%
Vivo Capital, LLC
1,552,685US$13.0m-33.3%1.11%
1.69%
Geode Capital Management, LLC
953,167US$8.0m-5.96%no data
1.4%
Citadel Advisors LLC
790,754US$6.6m-44.1%0.01%
1.36%
Adage Capital Management, L.P.
767,943US$6.4m-6.35%0.01%
1.28%
Affinity Asset Advisors, LLC
725,106US$6.1m-25.7%1.06%
1.2%
Nantahala Capital Management, LLC
675,000US$5.6m0%0.43%
0.89%
Sio Capital Management, LLC
504,887US$4.2m-1.05%1.96%
0.89%
Logos Global Management, L.P.
500,000US$4.2m0%0.53%
0.78%
Northern Trust Global Investments
438,341US$3.7m5.3%no data
0.56%
Charles Schwab Investment Management, Inc.
314,265US$2.6m152%no data
0.55%
Redmile Group, LLC
310,884US$2.6m0%0.15%
0.53%
Invesco Capital Management LLC
300,110US$2.5m67,600%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 00:14
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Astria Therapeutics, Inc. is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Liisa BaykoEvercore ISI
Joseph PantginisH.C. Wainwright & Co.
Carol WertherH.C. Wainwright & Co.